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Abstract 
We describe successful anesthetic management during living-donor liver transplantation in a 
63-year-old man with previous coronary artery bypass grafting that employed an in situ right 
gastroepiploic artery (RGEA).  Anesthesia was maintained with 1.5% isoflurane in air/oxygen and 
fentanyl.  A 5-lead electrocardiogram, transesophageal echocardiogram, and pacing pulmonary 
artery catheter evaluated cardiac function.  A pacing wire was inserted through the catheter to 
prepare for intraoperative severe bradyarrhythmia.  Olprinone and nicorandil were continuously 
infused to prevent the decrease in coronary arterial blood flow and the collapse of cardiac function.  
Avoiding disruption of circulation to coronary arteries through injury or spasm of the RGEA graft 
and preparing for the cardiac insufficiency during liver transplantation of a patient with previous 




The right gastroepiploic artery (RGEA) recently has become recognized as a safe and effective 
arterial conduit for coronary artery bypass grafting (CABG) [1,2].  However, abdominal surgery 
following previous CABG using an in situ RGEA graft can lead to inadvertent injury of the RGEA 
graft, which could endanger the critical blood supply to the coronary arteries [3,4].  We describe the 
anesthetic management of a patient during liver transplantation who had previously undergone 
CABG using an in situ RGEA. 
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Case Report 
A 63-year-old man (162 cm, 53 kg) was scheduled to undergo living-donor liver transplantation 
because of end-stage liver failure categorized as Child-Pugh grade C secondary to primary sclerosing 
cholangitis.  He had undergone CABG (the RGEA to the right coronary artery, the right internal 
thoracic artery to the left anterior descending branch and the left internal thoracic artery to the high 
lateral branch of the circumflex) to relieve unstable angina pectoris 3 years prior to liver 
transplantation.  He had never experienced anginal pain after CABG.  No ST-segment change was 
observed on the preoperative electrocardiogram.  Preoperative echocardiogram showed good 
ventricular function with left ventricular ejection fraction 68% and without pulmonary hypertension.  
Angiography revealed that the patent RGEA graft was located on the left lobe of the cirrhotic liver 
and that bilateral internal thoracic arteries maintained sufficient blood flow.  Thallium201 
myocardial stress scintigraphy detected no perfusion defect.  Preoperative upper gastrointestinal 
endoscopy revealed no apparent gastroesophageal varices.  Laboratory data before liver 
transplantation showed hemoglobin, 9.8 g·dl-1; hematcrit, 28.9%; prothrombin time (international 
normalized ratio), 65% (1.26); platelet count, 253,000 mm-3. 
Anesthesia was induced with propofol 80 mg and fentanyl 200 g.  Intubation of the trachea was 
facilitated with vecuronium 6 mg.  Anesthesia was maintained with 1.5% isoflurane in air/oxygen 
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and fentanyl.  One of the potent cardiotonic and vasodilating phosphodiesterase 3 inhibitors, 
olprinone, 0.2 g·kg-1·min-1, and a hybrid drug that combines characteristics of nitrates and KATP 
channel activators, nicorandil, 0.04 mg·kg-1·h-1, were continuously infused during anesthesia. 
A 5-lead electrocardiogram with continuous ST-segment trends of II, III and V5, cardiac output 
monitors and transesophageal echocardiogram (TEE) were used in addition to the standard monitors 
during anesthesia.  Cardiac output was measured using a pulmonary artery catheter (Swan-Ganz 
pacing pulmonary artery catheter; Edwards Lifesciences, Irvine, CA).  A pacing wire (Edwards 
Chandler Transluminal V-pacing probe; Edwards Lifesciences) was inserted through the right 
ventricular pacing port of the pulmonary artery catheter to prepare for severe bradycardia or 
complete atrioventricular block induced by RGEA graft insufficiency.  Sheath introducers 
(3-French) were placed into the right femoral artery and vein in preparation for emergent 
establishment of extracorporeal circulation, with cardiac surgeons on standby. 
Laparotomy identified the RGEA graft on the upper surface of the left lobe of the cirrhotic liver.  
In order to protect the RGEA graft from inadvertent injury, a two-stage explantation of the cirrhotic 
liver was performed [5], that is, left lateral segmentectomy followed by explantation of the remnant 
right lobe of the liver.  Pulsation of the RGEA graft was continually confirmed during the operation, 
and blood flow of the RGEA graft was detected using direct Doppler examination after completing 
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the implantation of a left lobe graft from a living donor. 
The values for mean arterial pressure, heart rate and cardiac index were 60-75 mmHg, 60-80 
beats·min-1 and 3.8 to 7.5 l·min-1·m-2 , respectively, which was maintained with dopamine and fluid 
supplementation with plasma protein fraction as required.  No drastic hemodynamic change was 
observed during reperfusion of the transplanted liver.  Homologous blood was transfused as needed 
to maintain an adequate hematocrit (approximately 25%).  Good bilateral ventricular contractions 
were observed on TEE throughout the anesthesia.  No intraoperative ST-segment change on the 
electrocardiogram was detected and temporary pacing was not required.  The duration of anesthesia 
and operation were 1154 min and 1015 min, respectively, with total blood loss of 1900 ml.  The 
postoperative course of the patient was uneventful.  He has been doing well for about 2 years since 
the liver transplantation. 
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Discussion 
We have successfully completed the anesthetic management of a patient with previous CABG 
using an in situ RGEA who underwent living-donor liver transplantation.  Because RGEA graft 
insufficiency can result in severe sequelae, we took extreme care to avoid inadvertent injury or 
spasm of the RGEA graft.  Furthermore, we prepared for intraoperative acute cardiac insufficiency 
because sudden hemodynamic instability can occur during graft reperfusion or inadvertent massive 
bleeding during liver transplantation. 
RGEA is an excellent conduit for coronary revascularization and has good long-term patency [1,2].  
Significant luminal narrowing caused by arteriosclerosis is rare in RGEA [6].  However, in patients 
who have undergone CABG with an in situ RGEA there is a risk of injury to the pedicle during 
subsequent abdominal surgery [3].  Even if an RGEA graft is not directly injured, traction or 
stretching of an RGEA graft may disturb its blood flow and cause myocardial ischemia [4].  RGEA 
is also more vulnerable to mechanical stimulation-induced spasm compared with the internal 
thoracic artery [7].  Although Kotoh did not mention the employment of any precautionary 
measures during surgery and they performed routine surgical procedures without trouble [3], we 
employed precautionary measures extensively with two preventive vasodilating drugs because liver 
transplantation is a hemodynamically unstable procedure. 
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To reduce the risk of spasm of the RGEA and intenrnal thoracic artery pedicles, we continuously 
infused one of the vasodilating phosphodiesterase 3 inhibitors, olprinone, 0.2 g·kg-1·min-1.  The 
clinical dose of olprinone is between 0.1 and 0.3 g·kg-1·min-1.  Olprinone induces relaxation of 
RGEA and internal thoracic artery [8] and decreases the rhythmical contraction of the RGEA as 
effectively as diltiazem [9].  Olprinone also enhances hepatosplanchnic blood flow and increases 
hepatic oxygen delivery [10,11], which might be advantageous during liver transplantation. 
Nicorandil is a hybrid drug that combines characteristics of nitrates and KATP channel activators, 
which possesses cardioprotective effect [12,13].  Nicorandil has been reported to reduce the 
frequency of perioperateive cardiac events in patients undergoing non-cardiac surgery with little 
effect on heart rate and arterial pressure [12].  It could be advantageous during liver transplantation 
that nicorandil has little effect on heart rate or blood pressure. 
Isoflurane is often used during anesthesia for liver transplantation because of its low incidence of 
liver injury [14].  Isoflurane also has anesthetic-induced preconditioning effect, which protects 
myocardium from infarction after ischemia [15-17].  Concurrent treatment of nicorandil and 
isoflurane is reported to enhance post-ischemic recovery of cardiac function [18].  Therefore, use of 
isoflurane might be beneficial during liver transplantation in a patient who had CABG. 
Acute reduction in right coronary artery blood flow, which can be caused by events such as 
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coronary spasm [19] or occlusion [20], can induce sinus bradycardia or complete atrioventricular 
block.  The pathogenesis of sinus bradycardia during right coronary artery occlusion is still unclear, 
but ischemia or infarction of the sinus atrial node or enhancement of parasympathetic activity known 
as the Bezold-Jarisch reflex is postulated.  In the present patient, the blood flow of RGEA was 
confirmed by angiography before liver transplantation.  Then, insufficiency of the RGEA graft 
which had been anastomosed to the right coronary artery could result in reduction of the right 
coronary blood flow followed by bradyarrhythmia or right ventricular dysfunction.  We applied a 
ventricular pacing pulmonary artery catheter to prepare for intraoperative severe bradycardia or 
complete atrioventricular block.  Although the appropriateness of the use of a pulmonary artery 
catheter is controversial [21], the use of a pacing pulmonary artery catheter is beneficial to cope with 
intraoperative cardiac collapse and severe bradyarrhythmia caused by the loss of right coronary 
artery blood flow. 
Although intraoperative TEE has proved invaluable and accepted for cardiovascular function 
monitoring, the presence of gastroesophageal varices has been considered an absolute as well as a 
relative contraindication to TEE, depending on the center and/or operator, because of the blind 
instrumentation that occurs within the esophagus and the perceived risk for bleeding [22].  Patient 
with end-stage liver disease presenting for liver transplantation commonly have coagulation disorder 
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and gastroesophageal varices [23].  However, recent studies have shown that TEE can be performed 
safely in patients undergoing liver transplantation [24] or with known gastroesophageal varices [25].  
In the report by Suriani [24], 25% of the patient examined had gastroesophageal varices.  TEE was 
used in 11.3% of transplant centers in the United States [26].  Because the present patient had no 
apparent gastroesophageal varices and did not have severe coagulation disorder, the use of TEE 
during liver transplantation is considered practically acceptable. 
In conclusion, we successfully completed the anesthetic management for liver transplantation in a 
patient who had CABG with an in situ RGEA.  Avoiding disruption of circulation to coronary 
arteries through injury or spasm of the RGEA graft and preparing for the cardiac insufficiency 
during liver transplantation is critical. 
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